EE272 Treating Patients With Non-Valvular Atrial Fibrillation With Apixaban Provides Substantial Consumer Value and Surplus Compared With Warfarin and Rivaroxaban

Abstract

Authors

K Johannesen N Atreja R Subash C Bektur M Hagan D Hines I Dunnett E Stawowczyk